BTG PLC (LSE:BTG) - Overview

Stock Report

BTG PLC BTG

Last Price
GBX600.00

Day Change
9.50|1.61%

As of 25/11/2016
17:01:45 GMT | GBX
Minimum 15 Minutes Delay.

Last Close590.50p
Day Range591.00 - 602.50
Mkt Cap2.31Bil
52-Wk Range554.97 - 739.50
Yield %0.00
ISINGB0001001592
Volume562,753
P/E36.53
P/S5.13
P/CF24.01

Share Price

Total Returns 25/11/2016

 Chg (%)  
More ...
BTG PLC-10.98 
FTSE 100 TR GBP-2.04
 
Financials
201420152016
More ...
Income Statement
Turnover290.50367.80447.50
Operating Profit27.3034.9056.50
Net Profit24.3033.6060.50
Reported EPS6.709.0015.60
Balance Sheet
Current Assets146.20207.60297.50
Non Current Assets565.50838.30851.30
Total Assets711.701,045.901,148.80
Current Liabilities87.80115.60125.00
Total Liabilities181.30287.30301.10
Total Equity530.40758.60847.70
Cash Flow
Operating Cash Flow55.5062.70101.80
Net Change in Cash-118.2034.8065.70
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201778.4816.762.0335.8017.61--
2018136.0823.9042.6225.110.59--

Regulatory News

DateSourceHeadline
More ...
25/11/2016|16:58RNSBTG PLC - Holding(s) in Company
15/11/2016|07:00RNSBTG PLC - Half-year Report
01/11/2016|13:08RNSBTG PLC - Total Voting Rights
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
01/09/2016Exercise of OptionDame Louise Makin600.001,2437,458.00
01/09/2016Exercise of OptionRolf Soderstrom600.003,10818,648.00
21/07/2016SaleDame Louise Makin676.3364,070433,325.00
21/07/2016SaleRolf Soderstrom676.3374,327502,696.00

Company Profile

BTG PLC is a specialist healthcare company, engaged in three areas, namely Specialty Pharmaceuticals, Interventional Medicine and Licensing.
 

Sector

Biotechnology

Market Position

164 of 1868 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE techMARK All Share ,FTSE All Share ,FTSE techMARK Focus

Outlook

(15/11/2016) "The business has performed well during the first half, and the outlook for the full year is strong"

Next Event 31/03/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)27.9913.7316.70
Div Yld (E)0.004.004.31
PEG (E)0.97-0.060.72
ROCE28.39203.7681.26
Op Mrgn12.94-15.16-15.56
EPS Grwth28.7910.7425.37
Dividends
PreviousLatest
More ...
Record Date25/07/9717/07/98
Ex-Div21/07/9713/07/98
Paid08/08/9707/08/98
Amnt0.880.92

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanGarry Watts
Chief Executive OfficerDame Louise Makin
Chief Financial OfficerRolf Soderstrom
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.